Home
About
Company
Organization
History
Team
Honor
Culture
Concept
Responsibility
Memoir
Video
News
Company notice
Company news
Media coverage
Innovation
Quality
HSE
Product
Halobios
Preparation
Raw material
Chinese Medicine
Health Products
Medical instrument
Service
Contact
Network
Stock code
603811
CN
Stock code
603811
Home
News
News
2024,04,27
Joint drugs have seen steady growth in revenue for many years, and fish oil health products have emerged as a rising star. Securities Times
2024,04,27
Realize a net profit of 163 million yuan in 2023 and adhere to a high proportion of dividends to give back to investors
2024,04,21
Cheng Yi Pharmaceutical insists on annual dividends to benefit all investors
Cheng Yi
Company notice
Company news
Media coverage
2022,09,21
Academician Ding Jian Investigates Cheng Yi Pharmaceutical Industry
2022,09,20
Marching from "imitation" to "research and innovation"
2022,08,27
Cheng Yi Successfully Signed a Contract with the Provincial Subtropical Crop Institute
2022,08,26
Breakthrough in achieving zero for Wenzhou's "Jian" brand
2022,08,25
Cheng Yi Pharmaceutical Fish Oil Soft Capsule Obtained Food Production License
2022,07,23
Adding New Members to the "Virgo" Amino Sugar Capsule
2022,06,17
Cheng Yi Pharmaceuticals Joins Hands with McKinsey Pharmaceuticals
2022,06,02
Chen Tiexiong and his delegation visited Cheng Yi for research and guidance
2022,05,30
How to choose the brand of sulfuric acid or hydrochloric acid glucosamine capsules?
2022,05,14
Win the future with innovation and planting momentum to promote common prosperity
2022,05,02
Welcome the return of Fu Bangwu, the recipient of the National May Day Labor Medal
2022,03,28
Cheng Yi won the 2021 Wenzhou City Mayor's Quality Award
<
1
...
3
4
5
...
16
>
Contact Us
view more